Changing Weight-Loss Injection Provider: How to Do It Safely

In short: If you are taking a prescribed weight-loss injection such as tirzepatide or semaglutide and want to change provider, do it with a clinician rather than on your own. A new prescriber needs evidence of your current treatment and dose to continue safely, and the MHRA advises against switching medicines or brands without professional advice. Only obtain these medicines from a registered pharmacy on a prescription issued after a proper consultation.

This guide, written by a Ready Health prescribing pharmacist, explains how to change provider safely and summarises the latest MHRA safety advice on GLP-1 and related weight-loss medicines.

Why do people change weight-management provider?

People move provider for many reasons, including cost, location, the level of clinical follow-up offered, or a change in personal circumstances. For example, when the manufacturer of tirzepatide increased its UK list price for private supply in September 2025, many patients reviewed their options. NHS supply was not affected by that change. Whatever the reason, continuity of safe care should come first.

How do I switch weight-loss injection provider safely?

1. Book a consultation with the new provider before your current supply runs out. This avoids gaps in treatment and rushed decisions.
2. Provide evidence of your current treatment. This usually means a copy of your prescription or dispensing record showing the medicine, the dose and when you last injected. A responsible prescriber will not issue a new supply without being able to verify this.
3. Share your full medical history. Include other medicines, weight history, any side effects, and conditions such as gallbladder or pancreas problems, diabetes or eating disorders.
4. Agree the right dose. If you have missed several doses, your prescriber may advise restarting at a lower dose to reduce side effects, rather than continuing where you left off.
5. Do not switch medicine or brand without advice. Different medicines and devices are not interchangeable dose for dose.

What does the MHRA say about safety with GLP-1 weight-loss medicines?

The Medicines and Healthcare products Regulatory Agency (MHRA) has published patient guidance on GLP-1 and related medicines, most recently updated in February 2026. Key points include:

• Stomach side effects: nausea, vomiting and diarrhoea are common and can occasionally cause severe dehydration.
• Pancreatitis: rare but serious. Seek urgent medical help for severe, persistent stomach pain that may spread to the back.
• Surgery and sedation: these medicines slow stomach emptying, which can increase the risk of inhaling stomach contents under general anaesthesia or deep sedation. Tell your healthcare team, including the anaesthetist, before any procedure.
• Pregnancy and breastfeeding: do not use these medicines while pregnant, trying to conceive or breastfeeding. Stop tirzepatide at least one month, and semaglutide at least two months, before trying for a baby.
• Contraception with tirzepatide: tirzepatide may make oral contraceptives less effective. Use a barrier method such as condoms for four weeks after starting and for four weeks after each dose increase, or consider a non-oral method such as a coil or implant.
• Eyesight: very rare cases of a sudden sight-threatening eye condition (NAION) have been linked to semaglutide. Seek urgent advice for any sudden change in vision.
• Mood: the MHRA has not found a causal link with depression or suicidal thoughts but continues to monitor this. Tell your prescriber about any changes in your mood.

How can I avoid fake or unsafe weight-loss injections?

The MHRA has warned about counterfeit pens and unauthorised products sold online, through social media and in beauty salons. To protect yourself:

• only obtain these medicines on a prescription following a consultation with a registered healthcare professional;
• check that the pharmacy is registered with the General Pharmaceutical Council (GPhC);
• be wary of products supplied as powder in vials that need mixing, as these are not authorised;
• report suspected side effects or suspect products through the MHRA Yellow Card scheme.

What should good weight-management care include?

Frequently asked questions

Can I just order my next pen from a different website?

You should not. Any new provider must carry out its own consultation and verify your current treatment before prescribing.

What if I have missed doses while changing provider?

Tell your new prescriber exactly when you last injected. Depending on the gap, they may recommend restarting at a lower dose to reduce the risk of side effects.

Can I switch from one weight-loss medicine to another?

Sometimes, but only under clinical supervision. The medicines differ in dosing and strength, and the MHRA advises against switching without professional advice.

Do I need to tell my GP?

It is strongly recommended. Your GP record should show all the medicines you take, particularly if you need surgery or other treatment.

Key takeaways

• Change provider through a proper consultation, before your supply runs out.
• Have evidence of your current prescription and dose ready.
• Do not switch medicines or brands without clinical advice.
• Follow MHRA advice on contraception, pregnancy, surgery and side effects.
• Only use medicines from a registered pharmacy on a valid prescription.

Sources and further reading

• MHRA: GLP-1 medicines for weight loss and diabetes, what you need to know
• MHRA Yellow Card scheme
• GPhC: Check the register
• NHS: Obesity treatment

Last reviewed: October 2026 by Shamir Patel, Independent Prescribing Pharmacist, Ready Health. This article is general information and does not replace advice from your own clinician. Brand names are trademarks of their respective owners.

If you would like to discuss weight management with a clinician in Standish, Wigan, find out about our weight management consultations. A prescriber will assess you individually and decide whether any medicine is suitable for you.